This market research report includes a detailed segmentation of the immunodiagnostic market in China by technology type (CLIA, ELISA, FIA, MIA, LFIA, and RIA), by product (reagent and instrument), by analyzer type (standalone analyzer and integrated analyzer), and by mode of operation (automated systems, semi-automated systems, and manual systems). The key vendors in this report are Roche Diagnostics, Abbott Diagnostics, Siemens Healthcare Diagnostics, Beckman Coulter, and Sysmex Medical Electronics.
Technavio has recently released its new market research report, immunodiagnostics market in China, which is expected to grow at a CAGR of around 18% between 2016 and 2020. Factors that can be attributed to this market’s growth are the introduction of healthcare reforms, funding, and promotion of local manufacturing by the Chinese government.
“Owing to the increase in automated and semi-automated systems in immunoassays analysis, the demand for chemiluminescence immunoassay (CLIAs) has accelerated in the recent years. CLIAs are preferred over traditional immunoassays due to their potential to examine and detect analytes speedily by consuming fewer reagents. These tests are integrated with automated analyzers, resulting in high-throughput analysis of samples in hospitals,” says Imran Mushtaq, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
Immunodiagnostics reagents account for around 82% of the immunodiagnostics market in China. These are biological components that can diagnose minute quantities of biological agents such as hormones, viruses, vitamins, or immunogenic substances in blood samples. Various companies are add new reagents to their product because of the increasing demand for high-throughput screening (HTS) with the aid of immunoassays.
The leading vendors in the immunodiagnostics market in China include Abbott, Beckman Coulter, bioMérieux, DiaSorin, Mindray, Roche Diagnostics, Siemens and Sysmex. Intense competition prevails in this market because of the growing demand for immunodiagnostics tests and their impact on medical decisions. Also, rise in the number of hospitals and increase in adoption of immunodiagnostic tests at grassroots levels have presented new opportunities for vendors.
Aore detailed analysis is available in the Technavio report, Immunodiagnostics market in China 2016-2020.
We can customize this report by other regions and specific segments upon request.
Other Related Reports:
